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Abstract Phagocytosis represents an important physiological 
trigger for the inducible expression of several genes in human 
neutrophils. Here, we report that a DNA-binding activity 
primarily consisting of the classical N F - K B heterodimer, p50/ 
RelA, is induced in phagocytosing neutrophils. Under these 
conditions, N F - K B activation was found to be a rapid and 
transient response, reaching a maximum by 10-15 min, and 
returning to near-basal levels by 30 min. In neutrophils under-
going the phagocytosis of opsonized yeasts, the onset of N F - K B 
activation was paralleled by a decline in immunoreactive IKB-OI 
protein levels, and the cellular IKB-OL pool was replenished by 30 
min, in agreement with our gel shift data. We conclude that 
N F - K B activation could constitute one of the mechanisms 
whereby the expression of KB-responsive genes is enhanced in 
phagocytosing neutrophils. To our knowledge, this represents the 
first demonstration that phagocytic stimuli can induce N F - K B 
activation in human neutrophils. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Since its initial discovery 10 years ago [1], the NF-KB/Rel 
family of transcription factors has emerged as a key compo-
nent of various biological processes, especially within the con-
text of inflammatory and immune responses, but also with 
respect to cell proliferation/differentiation and viral replica-
tion (reviewed in references [2] and [3]). In resting cells, N F -
K B dimers are sequestered in the cytoplasm through an asso-
ciation with inhibitor molecules, collectively referred to as I K B 
proteins. Amongst the latter, the best studied example is I K B -
cx, which becomes rapidly phosphorylated upon cell activation 
— an event which is thought to target the molecule for its 
subsequent degradation [4]. This in turn causes the release 
of N F - K B dimers which translocate into to the nucleus where 
they can bind to specific enhancer sequences in the promoter 
region of target genes. 
In keeping with its central involvement in host defence 
processes, the N F - K B pathway can be activated by a wide 
array of stimuli in various cells of the immune system such 
as lymphocytes, monocytes, and macrophages, amongst 
others [2,3]. Likewise, we recently showed that peripheral 
blood neutrophils respond to L P S \ pro-inflammatory cyto-
kines, and certain chemoattractants with a nuclear accumula-
tion of NF-KB/Rel proteins, which is paralleled by the onset 
of nuclear N F - K B DNA-binding activity [5]. These observa-
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tions are consistent with the known ability of neutrophils to 
accumulate m R N A transcripts encoding KB-dependent cyto-
kines and chemokines (such as T N F a , IL-1(3 and IL-8) in 
response to the same stimuli (extensively reviewed in reference 
[6]). Interestingly, neutrophils have also been reported to rap-
idly express high levels of m R N A transcripts encoding T N F a 
and IL-8 in response to another class of stimuli, i.e. phago-
cytic particles [7-9]. In this regard, yeast particles were even 
shown to represent a more potent stimulus than LPS for the 
early induction of IL-8 and T N F a m R N A accumulation (as 
well as secretion) in neutrophils [7-9]. These considerations 
therefore prompted us to determine whether phagocytosis 
might trigger N F - K B activation in human neutrophils. We 
now report that N F - K B is rapidly and transiently induced in 
neutrophils undergoing the phagocytosis of heat-killed yeast 
particles. This represents the first demonstrat ion that phago-
cytic stimuli can induce N F - K B activation in this cell type. 
2. Materials and methods 
2.1. Antibodies and reagents 
Rabbit antisera to human c-Rel (#1136, raised against an internal 
sequence downstream from the RHD), p65/RelA (#1207, against the 
N-terminal region), and p50/NFicBl (#1141, against the N-terminal 
region) were a generous gift from Dr. N.R. Rice (NCI-Frederick 
Cancer Research and Development Center, Frederick, MD). The spe-
cificity of these antisera has already been extensively characterized 
[10,11]. The antibody to iKB-a (sc-371) was purchased from Santa 
Cruz Biotechnology Inc. (Santa Cruz, CA). An oligonucleotide con-
taining tandemly repeated N F - K B sites identical to those of the HIV 
promoter (5'-gatcaGGGACTTTCCgctgGGGACTTTCC-3'; the NF-
KB binding sequence is indicated in capital letters) was kindly pro-
vided by Dr. G. Trinchieri (Wistar Institute, Philadelphia, PA). Re-
combinant human (rh) TNFa was obtained from Bachem Inc. (Han-
nover, Germany). Ficoll-Paque, T4 polynucleotide kinase, poly(dI-
dC), and Sephadex G25 spin columns were purchased from Pharma-
cia (Uppsala, Sweden); [y-32P]ATP was from 1CN (Cleveland, OH). 
RPMI-1640 was from GIBCO/BRL (Gaithersburg, MD), and low-
endotoxin FCS ( < 6 pg/ml) from Hyclone (Logan, UT). Polystyrene 
tubes for cell culture were from Greiner (Nurtingen, Germany). Apro-
tinin, acetylated BSA, diisopropyl fluorophosphate (DFP), leupeptin, 
LPS, pepstatin A, and phenylmethanesulphonyl fluoride (PMSF) were 
all from the Sigma Chemical Co. (St. Louis, MO). All other reagents 
were molecular biology grade, and all buffers and solutions were 
prepared using pyrogen-free clinical grade water. 
2.2. Cell isolation and culture 
Neutrophils were isolated from the peripheral blood of healthy 
donors under endotoxin-free conditions by a modification of the 
method of Boyum [12], as described earlier [7]. As determined by 
non-specific esterase cytochemistry, the final neutrophil suspensions 
consistently contained fewer than 0.5% monocytes, and neutrophil 
viability exceeded 98% after up to 3 h in culture, as determined by 
Trypan Blue exclusion. Purified neutrophils were resuspended in 
RPMI-1640 supplemented with 5% low-endotoxin FCS, at a final 
concentration of 5 X 106 cells/ml, and cultured in tubes at 37°C with 
frequent agitation. After being allowed to equilibrate for 15 min at 
37°C, neutrophils were stimulated with LPS (1 ug/ml), TNFa (100 VI 
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ml), or with heat-killed yeasts (5*. cerevisiae, at a particle/cell ratio of 
2:1) opsonized with IgG [13]. 
2.3. Electrophoretic mobility shift assays (EMSA) 
Neutrophils were cultured in the presence or absence of the stimuli 
for the indicated times; incubations were stopped by transferring ali-
quots of the cell suspensions into pre-cooled tubes containing equiv-
alent volumes of ice-cold RPMI-1640 supplemented with DFP (2 mM, 
final concentration) prior to centrifugation at 2000 Xg for 2 min at 
4°C. The cells were resuspended in ice-cold relaxation buffer (10 mM 
PIPES, pH 7.30, 30 mM KC1, 3 mM NaCl, 3.5 mM MgCl2, 1.25 mM 
EGTA, 0.5 mM DTT) containing an anti-protease cocktail (2 mM 
DFP, 1 mM PMSF, 1 mM AEBSF, and 10 ug/ml each of aprotinin, 
leupeptin and pepstatin A, final concentrations). Following a 10-min 
incubation on ice, cells were disrupted by nitrogen cavitation, using a 
modification of a previously published procedure [14] which we de-
scribed elsewhere [5]. Whole-cell extracts were subsequently prepared 
and analyzed in EMSA exactly as described previously [5]. 
2.4. Denaturing electrophoreses and immunoblots 
Whole-cell extracts were electrophoresed on 18% gels prepared ac-
cording to the method of Thomas and Kornberg [15]. Proteins were 
transferred onto nitrocellulose membranes in a Transblot semidry 
transfer cell (BioRad), and the membranes were blocked in TBS^ 
Tween containing 1.5% low-fat skimmed milk, as described [5]. Mem-
branes were subsequently exposed to a 1:300 dilution of commercial 
anti-lKB-oc antibody (sc-371) for 60 min at 37°C, washed 3 times with 
150 ml of TBS, and incubated in TBS with a horseradish peroxidase-
linked donkey anti-rabbit antibody, added to a final dilution of 
1:10000, for 45 min at 37°C. After three washes, the signal was 
revealed with the ECL reagent, according to the manufacturer's in-
structions. 
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Fig. 1. Induction of N F - K B DNA-binding activity in human neutro-
phils undergoing phagocytosis of yeast particles. Neutrophils were 
cultured for the indicated times (in minutes) in the presence of IgG-
opsonized yeast particles (Y-IgG), at a particle/cell ratio of 2:1. As 
a positive control, neutrophils were also stimulated with 1 |xg/ml 
LPS. Whole-cell extracts were then prepared and analyzed in 
EMSA using a consensus N F - K B oligonucleotide probe. The 
amount of extract used in the binding reactions was 22 (j.g of pro-
tein (representing ~ 730 000 cell equivalents). Both DNA-binding 
activities (A,B) present in the neutrophil extracts have been previ-
ously shown to display specificity in their interaction with our N F -
KB probe [5]. This experiment is representative of three. 
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Fig. 2. Characterization of the N F - K B DNA-binding activities de-
tected in phagocytosing neutrophils. Whole-cell extracts from neu-
trophils cultured for 10 min in the presence of Y-IgG were incu-
bated in the absence (—) or in the presence of antisera raised 
against p65/RelA, p50, or c-Rel, prior to the addition of labeled 
N F - K B probe and subsequent EMSA analysis. The amount of ex-
tract used in the binding reactions was 30 u.g of protein. This ex-
periment is representative of two. 
3. Results 
To determine whether N F - K B is activated in phagocytosing 
neutrophils, the cells were cultured in the presence of IgG-
opsonized yeast particles (hereafter referred to as Y-IgG) for 
varying lengths of time, prior to whole-cell extract preparation 
and subsequent E M S A analysis. As a positive control, neu-
trophils were also stimulated with 1 u,g/ml LPS or 100 U/ml 
T N F a , two stimuli previously shown to induce N F - K B in 
these cells [5]. As shown in Fig. 1, whole-cell extracts from 
unstimulated neutrophils contained a weak constitutive N F -
K B DNA-binding activity (complex A), as well as a faster-
migrating doublet (complex B) which strongly bound our 
N F - K B probe. By comparison, phagocytosis of Y-IgG (lanes 
2-4) led to a substantial increase in the intensity of complex 
A ; this effect was transient, being maximal at 10-15 min of 
stimulation, and decreasing thereafter. In three independent 
experiments, the effect of Y-IgG stimulation towards complex 
A was of lesser magnitude than that exerted by LPS or 
T N F a . Finally, in contrast to complex A, the detection of 
complex B was largely unaffected by any of the agonists 
used, in agreement with previously reported observations [5]. 
We next sought to determine the subunit composition of the 
N F - K B complexes detected in extracts from activated neutro-
phils. To this end, supershift experiments were performed, 
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Fig. 3. Inducible degradation of IKB-OC in phagocytosing neutrophils. 
Neutrophils were cultured for the indicated times (in minutes) in the 
presence Y-IgG or LPS, as described in the legend to Fig. 1. The 
resulting whole-cell extracts were then processed for electrophoresis 
(1.5 XlO6 cell equivalents per well) and immunoblotting using an 
anti-lKB-a antibody (sc 371). For comparative purposes, the immu-
noblot shown in this figure was performed using extracts from the 
same experiment as the one depicted in Fig. 1. This experiment is 
representative of three. MW, molecular weight markers (in kDa). 
using specific antisera raised against individual NF-KB/Rel 
proteins. As shown in Fig. 2, antisera to either RelA or p50 
completely supershifted the inducible complex A present in 
extracts from Y-IgG-treated neutrophils (Fig. 2, lanes 2 and 
3), while an antiserum to c-Rel only weakly affected the de-
tection of this DNA-binding activity (Fig. 2, lane 4). It there-
fore appears that the inducible complex A principally consists 
of p50/RelA dimers, and that it may additionally contain 
small amounts of c-Rel-containing complexes. The similarly 
migrating N F - K B complex present in extracts from either 
LPS- or TNF-treated neutrophils was identically affected by 
the same antisera [5], indicating that its composition is likely 
to be the same. By contrast, complex B was unaffected by any 
of the antisera, as previously observed [5]. 
In a final series of experiments, we examined whether the 
induction of N F - K B DNA-binding activity by phagocytic 
stimuli might be paralleled by a loss of iKB-a, as previously 
observed in the case of TNFoc or LPS [5]. For this purpose, 
whole-cell extracts from Y-IgG-stimulated neutrophils were 
analyzed by immunoblot. Fig. 3 shows that relative to unstim-
ulated neutrophils (Fig. 3, lane 1), immunoreactive IKB-a 
levels had substantially decreased by 10 min in Y-IgG-stimu-
lated cells (Fig. 3, lane 2); under these conditions, the cellular 
pool of IKB-a was fully replenished by 30 min (Fig. 3, lane 3). 
By comparison, immunoreactive IKB-CC was almost entirely 
lost in neutrophils stimulated with LPS for 20 min, as previ-
ously observed [5]. Collectively, these observations are in good 
agreement with our gel shift data, insofar as the relative abil-
ity of the various stimuli to elicit N F - K B activation is mir-
rored by their respective ability to induce a transient decline in 
IKB-OC levels. 
4. Discussion 
The N F - K B pathway is known to become activated under 
such diverse conditions as oxidative stress, viral challenge and 
ultraviolet irradiation, as well as in response to soluble stimuli 
such as inflammatory cytokines and LPS [3]. In the current 
study, we report that yet another class of stimuli, opsonized 
phagocytic particles, have the ability to activate N F - K B . In 
phagocytosing neutrophils, N F - K B activation was found to be 
a rapid and transient phenomenon, as it was already maximal 
by 10-15 min, and had returned to near-basal levels by 30 min. 
Under these conditions, maximal N F - K B activation was 
paralleled by a decline in immunoreactive IKB-OC, which was 
however less marked than that observed following LPS or 
TNFoc challenge, consistent with the ability of the latter stim-
uli to activate N F - K B to a greater extent than Y-IgG. Never-
theless, it cannot be excluded that a rapid accumulation of 
newly synthesized IKB-OC might lead to an underestimation of 
the ability of Y-IgG to induce IKB-OC degradation. In keeping 
with this interpretation is that cellular IKB-OC levels were al-
ready replenished within 30 min in Y-IgG-treated neutrophils. 
Finally, the fast kinetics of IKB-CC re-synthesis might account 
for the relatively brief time interval over which N F - K B acti-
vation takes place in phagocytosing neutrophils. 
Although the sequence of events that link particle ingestion 
to N F - K B activation remains to be established, several clues 
point to the involvement of distinct cell surface receptors in 
this process. For instance, CR3 (CDllb/CD18) has been re-
ported to function as a receptor for unopsonized zymosan (a 
yeast cell wall constituent) in human neutrophils [16], based 
on its ability to specifically recognize the p-glucan moiety of 
zymosan [17]. Consistent with these observations is that the 
ingestion of unopsonized zymosan by neutrophils appears to 
be primarily dependent upon its (3-glucan content [18]. Inter-
estingly, stimulation of CR3 using agonistic monoclonal anti-
bodies was recently shown to induce the formation of a nu-
clear N F - K B DNA-binding activity consisting of p50/RelA in 
peripheral blood monocytes, as well as in HIV-infected mono-
cytic cell lines [19]. Taken together, the above considerations 
raise the possibility that the effect of yeast phagocytosis to-
wards N F - K B activation might be mediated (at least in part) 
by CR3 in neutrophils. On a related note, the phagocytosis of 
zymosan by neutrophils has been observed to promote micro-
tubule assembly within 3 minutes, followed by microtubule 
disassembly after 5-9 min [20]. Again, it is interesting to 
note that microtubule depolymerization is a process that has 
been shown to result in N F - K B activation [21]. Thus, cytoske-
letal re-arrangements could represent one of the mechanisms 
whereby yeast phagocytosis (possibly through CR3) activates 
N F - K B . In addition to CR3, the ingestion of Y-IgG involves 
the participation of Fey receptors, and recent studies have 
established a link between Fey receptor engagement and 
N F - K B activation. For instance, cross-linking of Fey receptors 
using agonistic monoclonal antibodies or adherent human 
IgG was shown to induce N F - K B activation in monocytic 
THP-1 cells [22]. Similarly, nuclear N F - K B DNA-binding ac-
tivities were induced in J774 murine macrophage-like cells 
following culture in the presence of immobilized mouse 
IgG2a [23]. Thus, our finding that the ingestion of Y-IgG-
coated particles results in N F - K B activation might reflect the 
generation of distinct signals through both Fey receptors and 
CR3. 
In conclusion, our data suggest that N F - K B activation 
could represent one of the molecular bases underlying the 
inducible expression of KB-dependent genes (and in particular 
those encoding TNFoc and IL-8) observed in peripheral blood 
neutrophils undergoing the phagocytosis of yeasts or related 
products, such as zymosan [7-9,24,25]. Consistent with this 
conclusion is that in phagocytosing neutrophils, activation 
of N F - K B is an early event which directly precedes the accu-
mulation of TNFoc and IL-8 mRNA transcripts. In this re-
gard, previous studies from our laboratory have established 
that Y-IgG phagocytosis up-regulates IL-8 and TNFoc mRNA 
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steady-state levels within 45-60 min [7,9]. It must be stressed 
however, that Y-IgG represents a stronger stimulus than LPS 
for the early accumulation IL-8 and TNFoc m R N A transcripts 
in neutrophils [7-9], while we show herein that phagocytic 
particles activate N F - K B to a lesser extent than LPS. This 
therefore indicates that additional processes (aside from N F -
K B activation) are involved in the regulation of cytokine and 
chemokine gene expression in phagocytosing neutrophils. In a 
broader context, the ability of phagocytic particles to activate 
N F - K B in neutrophils raises the possibility that other phago-
cytes might similarly respond to the same stimuli. In partic-
ular, monocytes and macrophages are known to ingest a vari-
ety of targets, resulting in an enhanced expression of K B -
responsive genes such as those encoding T N F a , IL-1(3, IL-6, 
and IL-8 [7-9,24,26]. Moreover, the engagement of receptors 
involved in phagocytosis leads to N F - K B activation in both 
monocytic and macrophage-like cell lines [19,22,23]. Studies 
are in progress to determine whether N F - K B activation is a 
general consequence of phagocytosis in various cell types. 
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